Microtiter plate-based chemistry and in situ screening: SuFEx-enabled lead discovery of selective AChE inhibitors

References

• Liu Z, Li J, Li S, Li G, Sharpless KB, Wu P. SuFEx click chemistry enabled late-stage drug functionalization. J Am Chem Soc. 2018;140(8):2919–2925.
   PubMed Web of Science ®Google Scholar
• Marra A, Dong J, Ma T, Giuntini S, Crescenzo E, Cerofolini L, Martinucci M, Luchinat C, Fragai M, Nativi C, et al. Protein glycosylation through sulfur fluoride exchange (SuFEx) chemistry: the key role of a fluorosulfate thiolactoside. Chemistry. 2018;24(71):18981–18987.
   PubMed Web of Science ®Google Scholar
• Qin H-L, Zheng Q, Bare GAL, Wu P, Sharpless KB. A heck-matsuda process for the synthesis of beta-arylethenesulfonyl fluorides: selectively addressable bis-electrophiles for SuFEx click chemistry. Angew Chem Int Ed Engl. 2016;55(45):14155–14158.
   PubMed Web of Science ®Google Scholar
• Li S, Wu P, Moses JE, Sharpless KB. Multidimensional SuFEx click chemistry: sequential sulfur(VI) fluoride exchange connections of diverse modules launched from an SOF4 hub. Angew Chem Int Ed Engl. 2017;56(11):2903–2908.
   PubMed Web of Science ®Google Scholar
• Zhao C, Rakesh KP, Ravidar L, Fang W-Y, Qin H-L. Pharmaceutical and medicinal significance of sulfur (SVI)-containing motifs for drug discovery: a critical review. Eur J Med Chem. 2019;162:679–734.
   PubMed Web of Science ®Google Scholar
• Oakdale JS, Kwisnek L, Fokin VV. Selective and orthogonal post-polymerization modification using sulfur(VI) fluoride exchange (SuFEx) and copper-catalyzed azide–alkyne cycloaddition (CuAAC) reactions. Macromolecules. 2016;49(12):4473–4479.
   Web of Science ®Google Scholar
• Dong J, Krasnova L, Finn MG, Sharpless KB. Sulfur(VI) fluoride exchange (SuFEx): another good reaction for click chemistry. Angew Chem Int Ed Engl. 2014;53(36):9430–9448.
   PubMed Web of Science ®Google Scholar
• Schimler SD, Cismesia MA, Hanley PS, Froese RDJ, Jansma MJ, Bland DC, Sanford MS. Nucleophilic deoxyfluorination of phenols via aryl fluorosulfonate intermediates. J Am Chem Soc. 2017;139(4):1452–1455.
   PubMed Web of Science ®Google Scholar
• Zelli R, Tommasone S, Dumy P, Marra A, Dondoni A. A click ligation based on SuFEx for the metal-free synthesis of sugar and iminosugar clusters. Eur J Org Chem. 2016;2016(30):5102–5116.
   Web of Science ®Google Scholar
• Supuran CT. Carbonic anhydrase inhibition and the management of hypoxic tumors. Metabolites. 2017;7:48.
   PubMed Web of Science ®Google Scholar
• Capasso C, Supuran CT. Sulfa and trimethoprim-like drugs – antimetabolites acting as carbonic anhydrase, dihydropteroate synthase and dihydrofolate reductase inhibitors. J Enzyme Inhib Med Chem. 2014;29(3):379–387.
   PubMed Web of Science ®Google Scholar
• Brik A, Lin Y-C, Elder J, Wong C-H. A quick diversity-oriented amide-forming reaction to optimize P-subsite residues of HIV protease inhibitors. Chem Biol. 2002;9(8):891–896.
   PubMedGoogle Scholar
• Zhang Z, Zhang S-L, Wu C, Li H-H, Zha L, Shi J, Liu X, Qin H-L, Tang W. Sulfur-fluoride exchange (SuFEx)-enabled lead discovery of AChE inhibitors by fragment linking strategies. Eur J Med Chem. 2023;257:115502.
   PubMed Web of Science ®Google Scholar
• Mamidyala SK, Finn MG. In situ click chemistry: probing the binding landscapes of biological molecules. Chem Soc Rev. 2010;39(4):1252–1261.
   PubMed Web of Science ®Google Scholar
• Davies P, Maloney A. Selective loss of central cholinergic neurons in Alzheimer’s disease. Lancet. 1976;2(8000):1403.
   PubMed Web of Science ®Google Scholar
• Masson P, Froment MT, Bartels CF, Lockridge O. Asp 7O in the peripheral anionic site of human butyrylcholinesterase. Eur J Biochem. 1996;235(1–2):36–48.
   PubMedGoogle Scholar
• Li Q, He S, Chen Y, Feng F, Qu W, Sun H. Donepezil based multi-functional cholinesterase inhibitors for treatment of Alzheimer’s disease. Eur J Med Chem. 2018;158:463–477.
   PubMed Web of Science ®Google Scholar
• Jiang X, Zhang Z, Zuo J, Wu C, Zha L, Xu Y, Wang S, Shi J, Liu X-H, Zhang J, et al. Novel cannabidiol-carbamate hybrids as selective BuChE inhibitors: Docking-based fragment reassembly for the development of potential therapeutic agents against Alzheimer’s disease. Eur J Med Chem. 2021; 223:113735.
   PubMed Web of Science ®Google Scholar
• Shadrack WL, Qin HL, Tang HL. Transition metal-free regioselective synthesis of triazolyl aliphatic sulfonyl fluorides. Tetrahedron. 2021;98:132425.
   Web of Science ®Google Scholar
• Wu C, Zhang G, Zhang Z-W, Jiang X, Zhang Z, Li H, Qin H-L, Tang W. Structure–activity relationship, in vitro and in vivo evaluation of novel dienyl sulphonyl fluorides as selective BuChE inhibitors for the treatment of Alzheimer’s disease. J Enzyme Inhib Med Chem. 2021;36(1):1860–1873.
   PubMed Web of Science ®Google Scholar
• Fu Y, Zhang D, Kang T, Guo Y-Y, Chen W-G, Gao S, Ye F. Fragment splicing-based design, synthesis and safener activity of novel substituted phenyl oxazole derivatives. Bioorg Med Chem Lett. 2019;29(4):570–576.
   PubMed Web of Science ®Google Scholar
• Akıncıoğlu H, Gülçin İ. Potent acetylcholinesterase inhibitors: potential drugs for Alzheimer’s disease. Mini Rev Med Chem. 2020;20(8):703–715.
   PubMed Web of Science ®Google Scholar
• Walczak-Nowicka ŁJ, Herbet M. Acetylcholinesterase inhibitors in the treatment of neurodegenerative diseases and the role of acetylcholinesterase in their pathogenesis. Int J Mol Sci. 2021;22:9290.
   PubMed Web of Science ®Google Scholar
• de Almeida JSFD, Dolezal R, Krejcar O, Kuca K, Musilek K, Jun D, França TCC. Molecular modeling studies on the interactions of aflatoxin B1 and its metabolites with human acetylcholinesterase. II. Interactions with the catalytic anionic site (CAS). Toxins (Basel). 2018;10:389.
   PubMed Web of Science ®Google Scholar
• Ordentlich A, Barak D, Kronman C, Flashner Y, Leitner M, Segall Y, Ariel N, Cohen S, Velan B, Shafferman A, et al. Dissection of the human acetylcholinesterase active center determinants of substrate specificity. Identification of residues constituting the anionic site, the hydrophobic site, and the acyl pocket. J Biol Chem. 1993;268(23):17083–17095.
   PubMed Web of Science ®Google Scholar
• Joubert J, Kapp E. Discovery of 9-phenylacridinediones as highly selective butyrylcholinesterase inhibitors through structure-based virtual screening. Bioorg Med Chem Lett. 2020;30(9):127075.
   PubMed Web of Science ®Google Scholar
• de Andrade P, Mantoani SP, Gonçalves Nunes PS, Magadán CR, Pérez C, Xavier DJ, Hojo ETS, Campillo NE, Martínez A, Carvalho I, et al. Highly potent and selective aryl-1,2,3-triazolyl benzylpiperidine inhibitors toward butyrylcholinesterase in Alzheimer’s disease. Bioorg Med Chem. 2019;27(6):931–943.
   PubMed Web of Science ®Google Scholar
• Lee SG, Chmielewski J. Rapid synthesis and in situ screening of potent HIV-1 protease dimerization inhibitors. Chem Biol. 2006;13(4):421–426.
   PubMedGoogle Scholar
• Wu C-Y, Chang C-F, Chen JS-Y, Wong C-H, Lin C-H. Rapid diversity-oriented synthesis in microtiter plates for in situ screening: discovery of potent and selective alpha-fucosidase inhibitors. Angew Chem Int Ed Engl. 2003;42(38):4661–4664.
   PubMed Web of Science ®Google Scholar
• Liang F-S, Brik A, Lin Y-C, Elder JH, Wong C-H. Epoxide opening in water and screening in situ for rapid discovery of enzyme inhibitors in microtiter plates. Bioorg Med Chem. 2006;14(4):1058–1062.
   PubMed Web of Science ®Google Scholar
• Jahnke W, Erlanson DA, de Esch IJP, Johnson CN, Mortenson PN, Ochi Y, Urushima T. Fragment-to-lead medicinal chemistry publications in 2019. J Med Chem. 2020;63(24):15494–15507.
   PubMed Web of Science ®Google Scholar
• Nagar S, Argikar UA, Tweedie DJ. Enzyme kinetics in drug metabolism: fundamentals and applications. Methods Mol Biol. 2014;1113:1–6.
   PubMedGoogle Scholar
• Larik FA, Shah MS, Saeed A, Shah HS, Channar PA, Bolte M, Iqbal J. New cholinesterase inhibitors for Alzheimer’s disease: structure activity relationship, kinetics and molecular docking studies of 1-butanoyl-3-arylthiourea derivatives. Int J Biol Macromol. 2018;116:144–150.
   PubMed Web of Science ®Google Scholar
• Park JW, Ha YM, Moon K-m, Kim S-r, Jeong HO, Park YJ, Lee HJ, Park JY, Song YM, Chun P, et al. De novo tyrosinase inhibitor: 4-(6,7-dihydro-5H-indeno[5,6-d]thiazol-2-yl)-benzene-1,3-diol (MHY1556). Bioorg Med Chem Lett. 2013;23(14):4172–4176.
   PubMed Web of Science ®Google Scholar
• Tada H, Shiho O, Kuroshima K, Koyama M, Tsukamoto K. An improved colorimetric assay for interleukin 2. J Immunol Methods. 1986;93(2):157–165.
   PubMed Web of Science ®Google Scholar
• Liu J, Zhang L, Liu D, Li B, Zhang M. Neuroprotective effects of extracts from the radix curcuma aromatica on H2O2-induced damage in PC12 cells. Comb Chem High Throughput Screen. 2018;21(8):571–582.
   PubMed Web of Science ®Google Scholar
• Hajialyani M, Hosein Farzaei M, Echeverría J, et al. Hesperidin as a neuroprotective agent: a review of animal and clinical evidence. Molecules. 2019;24:648.
   PubMed Web of Science ®Google Scholar
• Di L, Kerns EH, Bezar IF, Petusky SL, Huang Y. Comparison of blood–brain barrier permeability assays: in situ brain perfusion, MDR1-MDCKII and PAMPA-BBB. J Pharm Sci. 2009;98(6):1980–1991.
   PubMed Web of Science ®Google Scholar
• Di L, Kerns EH, Fan K, McConnell OJ, Carter GT. High throughput artificial membrane permeability assay for blood-brain barrier. Eur J Med Chem. 2003;38(3):223–232.
   PubMed Web of Science ®Google Scholar
• Takeda S, Hashimoto T, Roe AD, Hori Y, Spires-Jones TL, Hyman BT. Brain interstitial oligomeric amyloid increases with age and is resistant to clearance from brain in a mouse model of Alzheimer’s disease. FASEB J. 2013;27(8):3239–3248.
   PubMed Web of Science ®Google Scholar
• Hampel H, Mesulam M-M, Cuello AC, Farlow MR, Giacobini E, Grossberg GT, Khachaturian AS, Vergallo A, Cavedo E, Snyder PJ, et al. The cholinergic system in the pathophysiology and treatment of Alzheimer’s disease. Brain. 2018;141(7):1917–1933.
   PubMed Web of Science ®Google Scholar